OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
15
Results
Show all
Save search
Copy query
Show results for
Unknown
(15)
Publication Date
Release Date
2025
(3)
2024
(3)
2021
(3)
2022
(2)
2026
(1)
2023
(1)
2020
(1)
2016
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Population-specific polygenic risk scores for people of Han Chinese ancestry.
Not available
S-EPMC12675292
|
biostudies-literature
Cite
Clinical impact of pharmacogenetic risk variants in a large chinese cohort.
Not available
S-EPMC12241563
|
biostudies-literature
Cite
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies.
Not available
S-EPMC12675286
|
biostudies-literature
Cite
Low-Density Lipoprotein Cholesterol and Mortality in Patients With Intracerebral Hemorrhage in Taiwan.
Not available
S-EPMC8802633
|
biostudies-literature
Cite
Correlates and consequences of atrial fibrillation in a prospective study of 25 000 participants in the China Kadoorie Biobank.
Not available
S-EPMC10989653
|
biostudies-literature
Cite
Probing CP symmetry and weak phases with entangled double-strange baryons.
Not available
S-EPMC9159954
|
biostudies-literature
Cite
Extracting the femtometer structure of strange baryons using the vacuum polarization effect.
Not available
S-EPMC11470094
|
biostudies-literature
Cite
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Not available
S-EPMC10207856
|
biostudies-literature
Cite
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977
|
biostudies-literature
Cite
Adjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.
Not available
S-EPMC9126186
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets